Invention Grant
- Patent Title: Anti-CD43 antibody and use thereof for cancer treatment
-
Application No.: US15767179Application Date: 2016-10-12
-
Publication No.: US10676531B2Publication Date: 2020-06-09
- Inventor: Kwon Pyo Hong , Sangsoon Yoon , Irene Koukoulas , Vincent Batori , Briony Cristiano , David S Wilson, Jr. , George Kopsidas
- Applicant: Aprogen KIC Inc.
- Applicant Address: KR Seongnam-si
- Assignee: APROGEN KIC INC.
- Current Assignee: APROGEN KIC INC.
- Current Assignee Address: KR Seongnam-si
- Agency: Lex IP Meister, PLLC
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@69cad65b
- International Application: PCT/KR2016/011428 WO 20161012
- International Announcement: WO2017/065493 WO 20170420
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K39/395 ; A61P35/00 ; A61K45/06 ; G01N33/50 ; G01N33/574 ; A61K39/00 ; A61K47/68 ; A61K38/16
Abstract:
Provided is an antibody for treating a cancer, more specifically, an anti-CD43 antibody binding to an extracellular domain of CD43, compositions for treating a cancer or inhibiting a cancer stem cell comprising the antibody as an active ingredient, and methods for screening an agent of inhibiting a cancer stem cell.
Public/Granted literature
- US20190016813A1 ANTI-CD43 ANTIBODY AND USE THEREOF FOR CANCER TREATMENT Public/Granted day:2019-01-17
Information query
